In a study involving 175 patients with SDC, Hirai et al. reported that 18% of patients were classified as PD-L1 positive (tumor proportion score ≥ 1%), and the positive PD-L1 expression was associated with worse progression-free survival (PFS) and OS in multivariate analysis [28]. The gene discussed is CD274; the disease is neoplasm.